158 related articles for article (PubMed ID: 26112162)
1. Fecal Calprotectin and serum chromogranin A as potential biomarkers of irritable bowel syndrome symptom severity.
Pletikosic S; Plavsic I; Hauser G; Tkalcic M
Med Hypotheses; 2015 Sep; 85(3):339-42. PubMed ID: 26112162
[TBL] [Abstract][Full Text] [Related]
2. Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms?
Ohman L; Stridsberg M; Isaksson S; Jerlstad P; Simrén M
Am J Gastroenterol; 2012 Mar; 107(3):440-7. PubMed ID: 22233694
[TBL] [Abstract][Full Text] [Related]
3. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.
Gracie DJ; Williams CJ; Sood R; Mumtaz S; Bholah MH; Hamlin PJ; Ford AC
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome.
El-Salhy M; Lomholt-Beck B; Hausken T
Scand J Gastroenterol; 2010 Dec; 45(12):1435-9. PubMed ID: 20602602
[TBL] [Abstract][Full Text] [Related]
5. Moderate to severe and prolonged left lower-abdominal pain is the best symptom characterizing symptomatic uncomplicated diverticular disease of the colon: a comparison with fecal calprotectin in clinical setting.
Tursi A; Elisei W; Picchio M; Giorgetti GM; Brandimarte G
J Clin Gastroenterol; 2015 Mar; 49(3):218-21. PubMed ID: 24583746
[TBL] [Abstract][Full Text] [Related]
6. Coexisting irritable bowel-like symptoms in inflammatory bowel disease in remission is associated with impaired social functioning and increased bodily pain.
Jelsness-Jørgensen LP; Bernklev T; Moum B
Gastroenterol Nurs; 2014; 37(4):280-7. PubMed ID: 25078042
[TBL] [Abstract][Full Text] [Related]
7. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.
Caviglia GP; Pantaleoni S; Touscoz GA; Adriani A; Rosso C; Smedile A; Pellicano R; Astegiano M; Bresso F
Scand J Gastroenterol; 2014 Dec; 49(12):1419-24. PubMed ID: 25369978
[TBL] [Abstract][Full Text] [Related]
8. The role of serum chromogranin A in diarrhoea predominant irritable bowel syndrome.
Sidhu R; McAlindon ME; Leeds JS; Skilling J; Sanders DS
J Gastrointestin Liver Dis; 2009 Mar; 18(1):23-6. PubMed ID: 19337629
[TBL] [Abstract][Full Text] [Related]
9. [Fecal calprotectin in differential diagnosis of irritable bowel syndrome].
Li XG; Lu YM; Gu F; Yang XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):310-3. PubMed ID: 16778979
[TBL] [Abstract][Full Text] [Related]
10. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.
Andréasson K; Ohlsson B; Mandl T
Arthritis Res Ther; 2016 Jan; 18():9. PubMed ID: 26759247
[TBL] [Abstract][Full Text] [Related]
12. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome.
El-Salhy M; Wendelbo IH; Gundersen D
Mol Med Rep; 2013 Apr; 7(4):1241-4. PubMed ID: 23426642
[TBL] [Abstract][Full Text] [Related]
13. Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission.
Jonefjäll B; Strid H; Ohman L; Svedlund J; Bergstedt A; Simren M
Neurogastroenterol Motil; 2013 Sep; 25(9):756-e578. PubMed ID: 23731196
[TBL] [Abstract][Full Text] [Related]
14. Role of fecal calprotectin in the diagnosis and treatment of segmental colitis associated with diverticulosis.
Tursi A; Elisei W; Giorgetti G; Aiello F; Brandimarte G
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):247-55. PubMed ID: 21769075
[TBL] [Abstract][Full Text] [Related]
15. Faecal calprotectin in colonic diverticular disease: a case-control study.
Tursi A; Brandimarte G; Elisei W; Giorgetti GM; Inchingolo CD; Aiello F
Int J Colorectal Dis; 2009 Jan; 24(1):49-55. PubMed ID: 18941760
[TBL] [Abstract][Full Text] [Related]
16. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.
Di Nardo G; Barbara G; Cucchiara S; Cremon C; Shulman RJ; Isoldi S; Zecchi L; Drago L; Oliva S; Saulle R; Barbaro MR; Stronati L
Neurogastroenterol Motil; 2014 Feb; 26(2):196-204. PubMed ID: 24304324
[TBL] [Abstract][Full Text] [Related]
17. Changes in Fecal Calprotectin After Rifaximin Treatment in Patients With Nonconstipated Irritable Bowel Syndrome.
Lee SH; Kim CR; Kim KN
Am J Med Sci; 2019 Jan; 357(1):23-28. PubMed ID: 30611316
[TBL] [Abstract][Full Text] [Related]
18. Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study.
David LE; Surdea-Blaga T; Dumitrascu DL
Sao Paulo Med J; 2015; 133(4):343-9. PubMed ID: 26039537
[TBL] [Abstract][Full Text] [Related]
19. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome.
El-Salhy M; Mazzawi T; Gundersen D; Hausken T
Mol Med Rep; 2012 Dec; 6(6):1223-5. PubMed ID: 22992886
[TBL] [Abstract][Full Text] [Related]
20. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
